Biocorrx (OTCMKTS:BICX) Announces Earnings Results

Biocorrx (OTCMKTS:BICX – Get Free Report) released its quarterly earnings data on Monday. The company reported ($0.03) EPS for the quarter, beating analysts’ consensus estimates of ($0.05) by $0.02, Zacks reports. The business had revenue of ($0.04) million during the quarter, compared to analyst estimates of $0.25 million.

Biocorrx Stock Up 7.7%

OTCMKTS BICX opened at $0.23 on Wednesday. Biocorrx has a 52 week low of $0.15 and a 52 week high of $1.28. The business’s fifty day simple moving average is $0.22 and its 200-day simple moving average is $0.30. The firm has a market cap of $6.91 million, a PE ratio of -5.64 and a beta of 0.07.

About Biocorrx

(Get Free Report)

BioCorRx, Inc. is a healthcare company focused on substance-use-disorder treatment and related products. Its BioCorRx Recovery Program is an outpatient approach that combines medication-assisted treatment with counseling and ongoing support for people seeking treatment for alcohol or opioid dependence. The company has also pursued pharmaceutical products intended to support addiction treatment, including long-acting formulations. Its business includes developing treatment offerings and working to make them available through healthcare providers.

Read More

Earnings History for Biocorrx (OTCMKTS:BICX)

Receive News & Ratings for Biocorrx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biocorrx and related companies with MarketBeat.com's FREE daily email newsletter.